Diseases
Companies
Products
Productz
Mechanisms of Action
Sites
CD Protein Inhibitors
>>
Phase 1
«
1
2
3
4
5
6
7
8
9
10
11
12
13
»
All trials
Active industry trials
Active owner-sponsored trials
Active trials
Export
Download options
Which format:
PDF
Excel Chart
TSV
Phase
N/A
1
2
3
4
Trials
0
1
2
3
4
5
6
7
8
9
10
AK131
/ Akesobio
AL003
/ Alector
ALLO-501
/ Allogene Therap
ALM201
/ Almac Discovery
AMC303
/ amcure
AMG 172
/ Amgen
AMG 340
/ Amgen
AMG 562
/ Amgen
AMG 794
/ Amgen
AMT-116 ADC
/ Multitude Therap
AN4005
/ Adlai Nortye
APVO210
/ Aptevo Therap
APVO414
/ Aptevo Therap
ASC61
/ Ascletis
ASD141
/ BRIM Biotech
ASKG915
/ Aosaikang Pharma
ASP2074
/ Astellas
ASP2138
/ Astellas
ASP2802
/ Astellas
ATG-037
/ Antengene
ATLCAR.CD138
/ UNC Lineberger Comprehensive Cancer Center
ATN-031
/ Antengene
AUR-103
/ Dr. Reddy’s
AUR-105
/ Dr. Reddy’s
AUR-106
/ Dr. Reddy’s
AUTO1/22
/ Autolus
AVA-001
/ Avalon GloboCare, BriSTAR Immunotech
AVC-001
/ AvenCell Therap, BMS
AVC-101
/ AvenCell Therap
AVC-201
/ AvenCell Therap
AVE9633
/ Sanofi
AWT020
/ Anwita Biosci
Ac225-DOTA-M5A
/ City of Hope, National Cancer Institute - Bethesda
Anti-CD19 CAR NK Cells
/ Allife Medical Science and Technology
Anti-CD19-CAR
/ Beijing Doing Biomedical
Anti-CD19/CD20/CD22 CAR T-Cells
/ The Ohio State University Comprehensive Cancer Center – Arthur G. James Cancer Hospital and Richard J. Solove Research Instit
Anti-CD22 CAR NK Cells
/ Allife Medical Science and Technology
Aurixim
(rituximab conjugate) / ChemRar
B1962
/ AP Biosciences
BA1106
/ Luye Group
BA1202
/ Luye Group
BA3182
/ BioAtla
BC008-1A
/ REMD Bio, Buchang Pharma
BC3448
/ Wuxi Biocity
BC8-SA
/ National Cancer Institute
BCMA-TriCAR-T
/ Timmune Biotech
BG-T19
/ Hedy Group
BH3120
/ Hanmi
BHV-1100
/ PeptiDream, Biohaven
BI 765179
/ Boehringer Ingelheim
«
1
2
3
4
5
6
7
8
9
10
11
12
13
»
